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expression and production of the pro-inflammatory cytokine
IL-12 in addition to the expected increased expression of
regulatory cytokine IL-10. As such, some of the CD4þ /
CD25þ cells in AA patients’ PBMC probably do not retain
true regulatory cell properties. Further research is required
to determine whether there is an effective functional
deficiency of CD4þ /CD25þ regulatory cells.
Using the mouse model, the CD4þ /CD25 cell subset
has been defined as the primary candidate pro-inflamma-
tory pathogenic cell subset with the capacity to induce AA
(McElwee et al, 2005). Examination of this cell subset in
humans with progressive AA reveals an activated state with
significantly increased expression of co-stimulatory ligands,
such as CD28, and production of pro-inflammatory cyto-
kines IL-12, IFN-g, and TNFa (Zo¨ller et al, 2004a, b). In
addition, CD4þ /CD25 cells from AA patients are relatively
resistant to apoptosis, as defined by a reduction in annexin
V binding, compared with the continued susceptibility to
apoptosis observed in CD4þ /CD25þ cells. Similar fea-
tures have been demonstrated in other autoimmune
disease mechanisms. These properties of the CD4þ /
CD25 cell population may raise the threshold of activity
that regulatory cells must attain to successfully promote
anergy or activation-induced cell death in CD4þ /CD25
cells and prevent autoimmunity. Boosting the number and
function of CD4þ /CD25þ regulatory cells and reducing
apoptosis resistance in the CD4þ /CD25 candidate
pathogenic cell population may be beneficial in the
treatment of AA. Although still very much a theoretical
option, research to develop such therapeutic approaches
for other autoimmune diseases is being conducted and
might be adapted for treating AA (Tang et al, 2004).
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Alopecia areata (AA) is a multifactorial disorder, in which
genetic and environmental factors combine to result in the
phenotype (Green and Sinclair, 2000). The prognosis of AA
is unpredictable and there is no definitive treatment. Several
lines of evidence support the polygenic inheritance of AA,
including the high prevalence of the trait, the Gaussian
curve of distribution of the phenotype, and heritability
among first-degree relatives (Aita and Christiano, 2001).
Genetic studies have been limited to association analyses,
which suggest that a permissive HLA status may potentiate
the development of AA (Welsh et al, 1994).
With the hypothesis that there is a genetic basis
underlying the susceptibility to develop AA, we initiated a
search for susceptibility genes by performing a genome-
wide scan in multiplex AA pedigrees. The genetic dissection
of complex traits has traditionally been focused on large
collections of small families (affected sib pairs, for example).
But it has recently been shown that a small sample of larger
pedigrees can potentially derive more robust results,
because of a reduced level of genetic heterogeneity
(‘‘noise’’), enrichment of genetic factors within families,
and the availability of the pedigree structure (Terwilliger and
Goring, 2000).
The ascertainment and diagnosis of the families studied
was undertaken by a dermatologist (Dr Abraham Zloto-
gorski), and using the diagnostic questionnaire developed
by the NIH AA Registry. We collected DNA from a total of 22
multiplex AA pedigrees, comprising 69 unaffected and 78
affected family members. We performed a genome-wide
scan using a panel of 324 microsatellite markers, with an
average marker spacing of 10 cM in all DNA samples.
Because of the complex nature of traits, it is expected
that a number of genetic components will be contributing to
the final presentation of the phenotype. For this reason, we
subjected the dataset derived from the genome-wide scan
to a combination of different statistical tests (Terwilliger and
Ott, 1994): (i) the heterogeneity LOD score, maximized over
four settings of the penetrance parameters (MAXHLOD); (ii)
the mean test for affected sib-pairs, as implemented in the
ANALYZE program (ASP); a test of allele sharing that uses
all sibs (ALLSIBS); and a likelihood version of the transmis-
sion disequilibrium test (TDT-LIKE). This strategy represents
a combination of parametric or model-based (MAXHLOD)
and non-parametric or model-free (ASP, ALLSIBS, and TDT-
LIKE) tests.
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We identified several chromosomal regions yielding
suggestive LOD scores, including the HLA region on
chromosome 6. These intervals could harbor potential
susceptibility loci for alopecia areata. In order to exclude
those regions that represent spurious positive scores and
to confirm and refine the true susceptibility loci, we are
currently undertaking a fine-mapping study in a larger group
of AA families.
We anticipate that these studies will lead to the
identification of AA susceptibility genes, and provide a
foundation for understanding the interactions of these
gene(s) with each other and with other variables such as
the immune system and environmental factors.
References
Aita VM, Christiano AM: The genetics of alopecia areata. Dermatol Ther 14:329–
339, 2001
Green J, Sinclair RD: Genetics of alopecia areata. Australas J Dermatol 41:213–
218, 2000
Terwilliger JD, Goring HH: Gene mapping in the 20th and 21st centuries:
Statistical methods, data analysis, and experimental design. Hum Biol
72:63–132, 2000
Terwilliger JD, Ott J: Handbook of Human Genetic Linkage. Baltimore: Johns
Hopkins, 1994
Welsh EA, Clark HH, Epstein SZ, Reveille JD, Duvic M: Human leukocyte antigen-
DQB103 alleles are associated with alopecia areata. J Invest Dermatol
103:758–763, 1994
Neurotrophins in Autoimmune Diseases:
Possible Implications for Alopecia Areata
T. N. Palkina,w A. A. Sharov, T. Y. Sharova, and
Vladimir A. Botchkarev
Department of Dermatology, Boston University School of Medicine, Boston,
Massachusetts, USA; wN.N. Blokhin’s Memorial Cancer Center, Russian
Academy of Medical Sciences, Moscow, Russia
Neurotrophins are a family of structurally and functionally
related polypeptides that include nerve growth factor (NGF),
brain-derived neurotrophic factor (BDNF), neurotrophin-3,
and neurotrophin-4 (for a review see Roux and Barker,
2002). They bind a 75kDa transmembrane neurotrophin
receptor (p75NTR), and also each neurotrophin binds a
distinct receptor of the Trk family. When p75NTR and Trk are
coordinately bound by neurotrophins, survival signal is
initiated through Trk. But in absence of the Trk, p75NTR is
activated alone to induce a variety of cellular responses
including apoptosis.
Increased evidence of data suggests that neurotrophins
play an important role during the development of auto-
immune disorders: NGF levels are significantly increased in
the synovium of patients affected by rheumatoid arthritis, in
the cerebrospinal fluid of patients with multiple sclerosis, in
plasma of patients affected by lupus erythematosus, and in
the skin of patients with systemic scleroderma (for a review
see Aloe and Tuveri, 1997). The mechanisms of neurotro-
phin involvement in pathogenesis of autoimmune disorders,
however, are largely unknown. Because neurotrophins are
expressed in skin affected by alopecia areata (AA) and
promote hair follicle regression in normal non-affected skin
(Botchkarev et al, 2000; Botchkarev, 2003), we asked if
neurotrophins may play a role in AA pathogenesis.
CD8 lymphocytes were isolated from involved skin and
peripheral blood of AA-affected C3H/HeJ mice as well as
from non-affected control mice. In contrast with peripheral
blood CD8 cells that displayed low p75 levels, cells from AA
involved skin expressed significantly higher p75 level
(po0.001, FACScan analysis). Multi-color immunofluores-
cence microscopy showed that p75-positive CD8 cells were
assembled specifically around the hair follicles as well as
inside the follicular epithelium.
To identify the phenotype of CD8 cells expressing
p75NTR in skin affected by AA, the expression of
interferon-g (IFN-g) and granzyme B as markers of effector
CD8 cells was studied by FACS analysis and immunofluor-
escence. p75NTR-positive CD8 cells also showed the
expression of IFN-g and granzyme B suggesting their
effector phenotype. By RT-PCR, however, these cells were
negative for Trk (TrkA, TrkB, TrkC) receptor expression,
suggesting that neurotrophin administration could induce
apoptosis of these inflammatory cells.
Consistent with this hypothesis, NGF- and BDNF-
induced apoptosis in CD8 cells isolated from skin of mice
affected by AA and cultured in vitro, as compared with
diluent alone. Furthermore, in vivo administration of agarose
beads soaked with NGF or BDNF resulted in significant
reduction of CD8 cells (po0.01) in AA-affected skin. These
data suggest that neurotrophin-stimulated apoptosis in CD8
cells may play a role as a part of the protective response
mechanisms limiting the development of AA and that
p75NTR agonists could be used as a novel therapeutic
intervention to arrest the development of AA.
References
Aloe L, Tuveri MA: Nerve growth factor and autoimmune rheumatic diseases. Clin
Exp Rheumatol 15:433–438, 1997
Botchkarev VA: Neurotrophins and their role in pathogenesis of alopecia areata.
J Investig Dermatol Symp Proc 8:195–198, 2003
Botchkarev VA, Botchkareva NV, Albers KM, Chen L-H, Welker P, Paus R: A role
for p75 neurotrophin receptor in the control of apoptosis-driven hair
follicle regression. FASEB J 14:1931–1942, 2000
Roux PP, Barker PA: Neurotrophin signaling through the p75 neurotrophin
receptor. Progr Neurobiol 67:203–233, 2002
The Functional Relevance of the Type 1
Cytokines IFN-c and IL-2 in Alopecia Areata
of C3H/HeJ Mice
P. Freyschmidt-Paul, M. Zo¨ller,w K. J. Mcelwee,
J. Sundberg,z R. Happle, and R. Hoffmann
Department of Dermatology, Philipp University Marburg, Marburg, Germany;
wGerman Cancer Research Centre, Heidelberg, Germany; zThe Jackson
Laboratory, Bar Harbor, Maine, USA
Alopecia areata (AA) was regarded as a type 1 (Th1, Tc1)-
mediated autoimmune disease of the hair follicle, because
type 1 cytokines interferon-g (IFN-g) and interleukin (IL)-2
are expressed in lesional AA skin. Recently we have shown
that the type 2 (Th2, Tc2) cytokine IL-10 also is expressed in
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